Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Annals of Hematology|April 3, 2020
Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myelomaEvangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, et al.
Blood Advances|April 23, 2021
Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOPToby A Eyre, William Wilson, Amy A Kirkwood, et al.
Blood Advances|April 15, 2026
Acalabrutinib in Waldenström macroglobulinemia yields durable responses with 5 years of follow-upRoger G Owen, Helen McCarthy, Shirley D'Sa, et al.
Blood Advances|September 11, 2020
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphomaStephen Booth, Hannah Plaschkes, Amy A Kirkwood, et al.
The Lancet. Haematology|December 24, 2019
Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 studyRoger G Owen, Helen McCarthy, Simon Rule, et al.
Pageof 3